Causes of Elevated Blood Urea Nitrogen (BUN) Levels

Pathophysiology and Primary Causes

Elevated BUN levels are primarily caused by renal dysfunction, but can also result from increased protein catabolism, dehydration, heart failure, gastrointestinal bleeding, or high protein intake, with the underlying mechanism being either decreased renal clearance or increased urea production, as noted by the European Society of Cardiology 1, 2
Urea is produced in the liver as a degradation product of proteins and is primarily filtered by the kidneys, according to the European Society of Cardiology 1
Unlike creatinine, 40-50% of filtered urea is reabsorbed in the proximal tubule, paralleling sodium and water reabsorption, as reported by the European Society of Cardiology 1
This reabsorption characteristic makes BUN levels sensitive to both renal function and volume status, as noted by the European Society of Cardiology 1
Acute kidney injury can cause reduced glomerular filtration rate, leading to decreased urea clearance, as reported by the International Journal of Oral Science 2
Heart failure can lead to reduced cardiac output, decreasing renal perfusion, and neurohormonal activation promotes fluid retention and renal vasoconstriction, according to the European Society of Cardiology 1
In heart failure, BUN is a better predictor of outcomes than creatinine or estimated GFR, reflecting both cardiac and renal dysfunction as well as neurohormonal activation, as noted by the European Society of Cardiology 1

Sampling errors can affect BUN measurement, including dilution of predialysis sample with saline, drawing sample after dialysis has started, and laboratory calibration errors, as reported by the American Journal of Kidney Diseases 3

The European Society of Cardiology notes that ACE inhibitors and ARBs can cause BUN elevation through hemodynamic effects on glomerular filtration, with increases up to 50% above baseline considered acceptable 4

The National Kidney Foundation recommends avoiding dilution of blood sample with saline, as it reduces measured BUN concentration, and notes that drawing sample after dialysis has started lowers BUN through solute removal, and laboratory calibration errors can affect accuracy, and timing of sample collection is critical for accurate assessment 5

Renal impairment is frequent among patients with heart failure, and its prevalence rises with greater heart‑failure severity, older age, and a history of hypertension or diabetes. 6
In heart‑failure cohorts, renal dysfunction markedly increases morbidity and mortality; BUN outperforms creatinine or estimated GFR as a prognostic marker because it reflects combined cardiac‑renal stress and neuro‑hormonal activation. 6

ACE inhibitors and ARBs can raise BUN by up to roughly 50 % above baseline (equivalent to a moderate rise in creatinine), an increase that is generally considered acceptable in clinical practice. 6
Initiation of ACE‑I or ARB therapy is typically linked to a mild, often transient deterioration in renal function, manifested by modest elevations in BUN and creatinine that usually resolve without permanent damage. 6

When BUN is elevated, clinicians should actively search for reversible contributors such as hypotension, volume depletion, ACE‑I/ARB‑related renal effects, concurrent nephrotoxic drugs (e.g., NSAIDs), and renal artery stenosis. 6

Increased intake of collagen, a high‑protein supplement, provides additional amino acids that are deaminated in the liver, leading to greater urea synthesis and consequently higher BUN concentrations even when renal function is normal. 7

In hospitalized adults with acute kidney injury receiving kidney replacement therapy, a protein provision of 2.5 g kg⁻¹ day⁻¹ markedly raised BUN production, necessitating an increase in dialysis dose to maintain adequate clearance. 7

Across diverse patient populations, BUN levels rise in a dose‑dependent manner with higher dietary protein intakes; the correlation persists independent of baseline kidney function. 7

In individuals with CKD, the amount of protein consumed can be accurately inferred from the rate of urea nitrogen appearance, confirming a direct mathematical relationship between protein intake and BUN concentration. 8

For patients who already have reduced renal function, high‑protein collagen supplementation may theoretically exacerbate azotemia (elevated BUN); clinicians should balance the nutritional benefits of collagen against the risk of worsening uremia. 7